Related Experiment Videos
Bone morphogenetic proteins in melanoma: angel or devil?
Mei-Yu Hsu1, Sherry Rovinsky, Sunita Penmatcha
1Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, 52242, USA. mei-yu-hsu@uiowa.edu
Cancer Metastasis Reviews
|June 30, 2005
Summary
Bone morphogenetic proteins (BMPs) play diverse roles in cell functions. This review explores BMP signaling in human cancers, focusing on their understudied role in cutaneous melanoma.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Bone morphogenetic proteins (BMPs), part of the TGF-beta superfamily, regulate crucial cellular processes like proliferation, apoptosis, and differentiation.
- While BMP pathways are implicated in various cancers, their specific role in human melanoma remains largely unexplored.
- BMPs exhibit context-dependent functions, acting as both oncogenes and tumor suppressors, necessitating system-specific investigation.
Purpose of the Study:
- To review the current knowledge of BMP signaling across different human cancers.
- To present original research data on BMPs in cutaneous melanoma.
- To highlight the biological significance of BMPs in melanoma development and progression.
Main Methods:
- Literature review of BMP signaling in human cancers.
- Analysis of original laboratory data concerning BMPs in cutaneous melanoma.
- Synthesis of existing knowledge with novel findings.
Main Results:
- BMP signaling pathways are dysregulated in numerous cancers.
- Evidence suggests complex and potentially dual roles for BMPs in melanoma.
- Specific BMPs may influence melanoma cell behavior, warranting further investigation.
Conclusions:
- BMPs represent a significant, yet under-characterized, factor in human melanoma.
- Understanding cell-specific BMP responses is crucial for deciphering their role in cancer.
- Further research into BMPs in melanoma could reveal novel therapeutic targets.